Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
about
Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.Replicon RNA Viral Vectors as VaccinesDendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity.Tetracycline-inducible packaging cell line for production of flavivirus replicon particlesKunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection.A call for replicating vector prime-protein boost strategies in HIV vaccine design.Long-term storage of DNA-free RNA for use in vaccine studiesFrom mice to humans - murine intelligence for human CD8+ T cell vaccine design.Mosquito cell-derived West Nile virus replicon particles mimic arbovirus inoculum and have reduced spread in mice.Memory cytolytic T-lymphocytes: induction, regulation and implications for vaccine design.Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription.Are trans-complementation systems suitable for hepatitis C virus life cycle studies?RNA-based viral vectors.A highly pathogenic porcine reproductive and respiratory syndrome virus candidate vaccine based on Japanese encephalitis virus replicon system.
P2860
Q27472925-E9367920-F2C8-4AC3-BC62-158443462AA2Q28076639-6B0F2695-A205-459A-A3F8-965C23C38A06Q34128906-95F18878-611C-441C-BEA6-43293D5A6C31Q34552578-BB942109-3471-46EF-94F6-EF8101082A13Q35300048-AD71F017-5028-48C7-B57B-C7F95448DC63Q35851801-79141F82-5345-462C-8867-80C0BD679ADDQ35920469-7F3EC6E5-6EF1-41B9-A404-3BAE38EE359AQ36065972-57ABD769-6749-469B-A3A6-320B1AC88462Q36276928-EA797F2D-7ECE-46B3-A892-FC480F745EFCQ36284560-42B5C046-C8E4-4451-B281-5325965FC78DQ36377208-5AAE3348-649E-4ADB-BDA0-38C4DBACB9F3Q37596892-BC8C0BBF-41E5-44B1-B77B-186005DE5AE4Q38089384-CEADBE17-F5F0-4EAE-BEC3-B787947BD6A0Q38266413-7F033021-86BB-4E08-A1AE-07819B84F981Q38663271-CF3EE6D4-F431-496F-8CFA-353FFB99B740
P2860
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
@ast
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
@en
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
@nl
type
label
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
@ast
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
@en
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
@nl
prefLabel
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
@ast
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
@en
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
@nl
P2093
P2860
P50
P1433
P1476
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development
@en
P2093
David Harrich
Itaru Anraku
Richard Linedale
P2860
P304
P356
10.1128/JVI.77.14.7796-7803.2003
P577
2003-07-01T00:00:00Z